Studies on protein-liposome coupling using novel thiol-reactive coupling lipids: Influence of spacer length and polarity

被引:34
作者
Fleiner, M [1 ]
Benzinger, P [1 ]
Fichert, T [1 ]
Massing, U [1 ]
机构
[1] Dept Clin Res, Tumor Biol Ctr, D-79106 Freiburg, Germany
关键词
D O I
10.1021/bc000101m
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
To optimize the preparation of immunoliposomes, we investigated the coupling of thiolated IgG and BSA to liposomes using a novel group of coupling lipids. All lipids consist of cholesterol as membrane anchor and a thiol-reactive maleimide headgroup, linked by a spacer that differs in length and polarity (ethylene glycol, tetraethylene glycol, PEG 400, PEG 1000, dodecyl). In addition, lipids differ in the electrophilicity of the maleimide group (p- or m-maleimidobenzoic ester). In the case of BSA, coupling efficiency strongly depended on the electrophilicity of the maleimide group as well as on the spacer polarity: The less electrophilic meta constitution seems to be an advantage over the p-maleimidobenzoic ester, resulting in higher coupling efficiency. Polar spacers (tetraethylene glycol, 46%) achieved a higher coupling efficiency than a nonpolar spacer with approximately the same length (dodecyl, 15%).When liposomes containing coupling lipids with the spacers tetraethylene glycol, PEG 400, and PEG 1000 were linked to BSA, coupling efficiencies were in a medium range and similar (41-46%) but were lower for the short ethylene glycol spacer (30%). In contrast, for IgG coupling efficiencies correlated with increasing spacer length. Pest results were obtained using coupling lipids with a long polar spacer (PEG 1000) (65%), whereas a coupling lipid bearing a short spacer (ethylene glycol) resulted in a low coupling efficiency of 12%.
引用
收藏
页码:470 / 475
页数:6
相关论文
共 38 条
[11]  
DVORAK HF, 1995, AM J PATHOL, V146, P1029
[12]  
DVORAK HF, 1988, AM J PATHOL, V133, P95
[13]   A NEW, SENSITIVE DETERMINATION OF PHOSPHATE [J].
EIBL, H ;
LANDS, WEM .
ANALYTICAL BIOCHEMISTRY, 1969, 30 (01) :51-&
[14]   Preparation and characterization of doxorubicin-loaded sterically stabilized immunoliposomes [J].
Emanuel, N ;
Kedar, E ;
Bolotin, EM ;
Smorodinsky, NI ;
Barenholz, Y .
PHARMACEUTICAL RESEARCH, 1996, 13 (03) :352-359
[15]   Seminars in medicine of the Beth Israel Hospital, Boston - Clinical applications of research on angiogenesis [J].
Folkman, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (26) :1757-1763
[16]   LIPOSOME FORMULATIONS WITH PROLONGED CIRCULATION TIME IN BLOOD AND ENHANCED UPTAKE BY TUMORS [J].
GABIZON, A ;
PAPAHADJOPOULOS, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (18) :6949-6953
[17]   Engineering liposomes for drug delivery: Progress and problems [J].
Gregoriadis, G .
TRENDS IN BIOTECHNOLOGY, 1995, 13 (12) :527-537
[18]   ATTACHMENT OF ANTIBODIES TO STERICALLY STABILIZED LIPOSOMES - EVALUATION, COMPARISON AND OPTIMIZATION OF COUPLING PROCEDURES [J].
HANSEN, CB ;
KAO, GY ;
MOASE, EH ;
ZALIPSKY, S ;
ALLEN, TM .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1995, 1239 (02) :133-144
[19]   Sterically stabilized Anti-HER2 immunoliposomes: Design and targeting to human breast cancer cells in vitro [J].
Kirpotin, D ;
Park, JW ;
Hong, K ;
Zalipsky, S ;
Li, WL ;
Carter, P ;
Benz, CC ;
Papahadjopoulos, D .
BIOCHEMISTRY, 1997, 36 (01) :66-75
[20]  
Kley JT, 1998, MONATSH CHEM, V129, P319, DOI 10.1007/PL00000090